Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Immunoglobulin Light-chain Amyloidosis 3 Pleural Effusion, Malignant 2 Amyloidosis 2 Tuberous Sclerosis 1 Skin Toxicity 1 Ras-wildtype Colorectal Cancer 1 Polycystic Ovary Syndrome 1 Pancreatic Neoplasms 1 Pain 1 Neoplasm Metastasis 1 Menstruation Disturbances 1 Lymphoma, Non-Hodgkin 1 Lymphangioleiomyomatosis 1 Intracranial Aneurysm 1 Hyperandrogenism 1 Hemangioma, Cavernous 1 Head and Neck Neoplasms 1 Exanthema 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Arteriovenous Malformations 1 Amyloidosis, Familial 1 Advanced Malignant Neoplasm 1 AA amyloidosis 1

Interventions

Fentanyl 19 Analgesia 15 Acupuncture Therapy 13 Oxycodone 12 Zoledronic Acid 11 Surveys and Questionnaires 10 nabiximols 9 Therapeutics 9 Morphine 9 Acetaminophen 9 Psychiatric Rehabilitation 8 Ketamine 8 Hydromorphone 7 Lidocaine 6 Ibandronic Acid 6 Radiotherapy 5 Early Intervention, Educational 5 Bupivacaine 5 Analgesics, Opioid 5 Yoga 4 Transcutaneous Electric Nerve Stimulation 4 Therapeutic Touch 4 Ropivacaine 4 Music Therapy 4 Methadone 4 Massage 4 Aromatherapy 4 alvimopan 3 Tapentadol 3 Saline Solution 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pain × Doxycycline × Clear all

NCT01847976 2019-09-06

OTT12-05

Ottawa Hospital Research Institute

Phase 2 Completed

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡